WallStSmart
GRCL

Gracell Biotechnologies Inc.

NASDAQ: GRCL · HEALTHCARE · BIOTECHNOLOGY

$10.25
+0.00% today

Updated 2026-06-05

Market cap
$989.87M
P/E ratio
P/S ratio
732.21x
EPS (TTM)
$-0.97
Dividend yield
52W range
$307 – $617
Volume
6.4M

Gracell Biotechnologies Inc. (GRCL) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+2.2%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+71.4%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+2.5%
Last 1 reports
Positive reaction rate
100%
1 of 1 quarters
Largest single-day move
+2.5%
2023-11-13
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2023-11-13$-0.10+50.0%$4.40$4.51+2.5%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2023-09-30$-0.20$-0.10+50.0%
2023-06-30$-0.40$-0.30+25.0%
2023-03-31$-0.39$-0.35+10.3%
2022-12-31$-0.17$-0.30-76.5%
2022-09-30$-0.13$-0.35-169.2%
2022-06-30$-0.07$-0.30-328.6%
2022-03-31$-0.21$-0.35-66.7%
2021-12-31$-0.33$-0.30+9.1%
2021-09-30$-0.12$-0.30-150.0%$366000.00
2021-06-30$-0.12$-0.20-66.7%
2021-03-31$-0.21$-0.25-19.0%
2020-12-31$-0.26$-0.16+38.5%

Frequently asked questions

Has Gracell Biotechnologies Inc. beaten earnings estimates?

Gracell Biotechnologies Inc. has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, averaging a +2.2% surprise over the last 4. A consistent beat record suggests management guides conservatively and the business has predictable momentum, which tends to support the stock through earnings season.

How does GRCL stock react to earnings?

GRCL has moved an average of +2.5% the day after earnings over its last 1 reports, finishing higher after 1 of them. Next-day moves show how the market digests results in the short term, and repeated dips on strong reports usually mean expectations were already priced in.